| Metastatic Pancreatic Cancer Global Clinical Trials Review, H1, 2012 |
| Publication Date |
Feb 2012 |
| Publisher |
GlobalData |
| Product Type |
Report |
| Pages |
122 |
| Single User License |
$
1000.00 |
| Site User License |
$
2000.00 |
| Corporate User License |
$
3000.00 |
|
|
Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase. |
Metastatic Pancreatic Cancer Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Metastatic Pancreatic Cancer Global Clinical Trials Review, H1, 2012" provides data on the Metastatic Pancreatic Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Pancreatic Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Pancreatic Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Metastatic Pancreatic Cancer 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Metastatic Pancreatic Cancer 25
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Metastatic Pancreatic Cancer Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Eli Lilly and Company 33
Clinical Trial Overview of Eli Lilly and Company 33
Taiho Pharmaceutical Co., Ltd. 34
Clinical Trial Overview of Taiho Pharmaceutical Co., Ltd. 34
Amgen Inc. 35
Clinical Trial Overview of Amgen Inc. 35
F. Hoffmann-La Roche Ltd. 36
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 36
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
OSI Pharmaceuticals, Inc. 38
Clinical Trial Overview of OSI Pharmaceuticals, Inc. 38
Chugai Pharmaceutical Co., Ltd. 39
Clinical Trial Overview of Chugai Pharmaceutical Co., Ltd. 39
Pfizer Inc. 40
Clinical Trial Overview of Pfizer Inc. 40
Rexahn Pharmaceuticals, Inc. 41
Clinical Trial Overview of Rexahn Pharmaceuticals, Inc. 41
Clovis Oncology, Inc. 42
Clinical Trial Overview of Clovis Oncology, Inc. 42
Celgene Corporation 43
Clinical Trial Overview of Celgene Corporation 43
Aduro BioTech 44
Clinical Trial Overview of Aduro BioTech 44
Exelixis, Inc. 45
Clinical Trial Overview of Exelixis, Inc. 45
PDL BioPharma, Inc. 46
Clinical Trial Overview of PDL BioPharma, Inc. 46
Astellas Pharma Inc. 47
Clinical Trial Overview of Astellas Pharma Inc. 47
ImClone LLC 48
Clinical Trial Overview of ImClone LLC 48
BioSante Pharmaceuticals, Inc. 49
Clinical Trial Overview of BioSante Pharmaceuticals, Inc. 49
MediGene AG 50
Clinical Trial Overview of MediGene AG 50
FibroGen, Inc. 51
Clinical Trial Overview of FibroGen, Inc. 51
Infinity Pharmaceuticals, Inc. 52
Clinical Trial Overview of Infinity Pharmaceuticals, Inc. 52
Clinical Trial Overview of Top Universities / Institutes / Hospitals 53
Dana-Farber Cancer Institute 53
Clinical Trial Overview of Dana-Farber Cancer Institute 53
Pancreatic Cancer Research Team 54
Clinical Trial Overview of Pancreatic Cancer Research Team 54
UCLA's Jonsson Comprehensive Cancer Center 55
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center 55
University Health Network 56
Clinical Trial Overview of University Health Network 56
Fox Chase Cancer Center 57
Clinical Trial Overview of Fox Chase Cancer Center 57
Sidney Kimmel Comprehensive Cancer Center 58
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 58
Centre Val d'Aurelle - Paul Lamarque 59
Clinical Trial Overview of Centre Val d'Aurelle - Paul Lamarque 59
Brown University 60
Clinical Trial Overview of Brown University 60
European Organization for Research and Treatment of Cancer 61
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 61
Academic Medical Centre 62
Clinical Trial Overview of Academic Medical Centre 62
The University of Chicago 63
Clinical Trial Overview of The University of Chicago 63
The University of Texas M. D. Anderson Cancer Center 64
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 64
University Hospital Basel 65
Clinical Trial Overview of University Hospital Basel 65
University of Oklahoma 66
Clinical Trial Overview of University of Oklahoma 66
University of Medicine and Dentistry New Jersey 67
Clinical Trial Overview of University of Medicine and Dentistry New Jersey 67
Massachusetts General Hospital 68
Clinical Trial Overview of Massachusetts General Hospital 68
The University of Iowa 69
Clinical Trial Overview of The University of Iowa 69
University of Connecticut Health Center 70
Clinical Trial Overview of University of Connecticut Health Center 70
University of Ulm 71
Clinical Trial Overview of University of Ulm 71
Asan Medical Center 72
Clinical Trial Overview of Asan Medical Center 72
Five Key Clinical Profiles 73
Appendix 118
Abbreviations 118
Definitions 118
Research Methodology 120
Secondary Research 120
About GlobalData 121
Contact Us 121
Disclaimer 121
Source 122List of Tables
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012* 14
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 15
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 16
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, BRIC Countries, 2012* 17
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 18
Metastatic Pancreatic Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, E7 Countries, 2012* 20
Metastatic Pancreatic Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Metastatic Pancreatic Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25
Metastatic Pancreatic Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012* 26
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 33
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Taiho Pharmaceutical Co., Ltd., 2012* 34
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012* 35
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012* 36
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 37
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by OSI Pharmaceuticals, Inc., 2012* 38
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Chugai Pharmaceutical Co., Ltd., 2012* 39
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 40
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Rexahn Pharmaceuticals, Inc., 2012* 41
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Clovis Oncology, Inc., 2012* 42
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012* 43
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Aduro BioTech, 2012* 44
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Exelixis, Inc., 2012* 45
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by PDL BioPharma, Inc., 2012* 46
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2012* 47
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ImClone LLC, 2012* 48
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by BioSante Pharmaceuticals, Inc., 2012* 49
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by MediGene AG, 2012* 50
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FibroGen, Inc., 2012* 51
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Infinity Pharmaceuticals, Inc., 2012* 52
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012* 53
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pancreatic Cancer Research Team, 2012* 54
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2012* 55
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2012* 56
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2012* 57
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012* 58
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Val d'Aurelle - Paul Lamarque, 2012* 59
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Brown University, 2012* 60
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2012* 61
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2012* 62
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2012* 63
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 64
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2012* 65
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oklahoma, 2012* 66
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2012* 67
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012* 68
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Iowa, 2012* 69
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Connecticut Health Center, 2012* 70
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Ulm, 2012* 71
Metastatic Pancreatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2012* 72List of Figures
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 15
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 16
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 18
Metastatic Pancreatic Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012* 20
Metastatic Pancreatic Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23
Metastatic Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 30
Metastatic Pancreatic Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32
GlobalData Methodology 120
| Title |
Date |
Price |
|
|
Jan 2013 |
$2000.00 |
|
| By Netscribes (India) Pvt. Ltd. |
| |
|
May 2012 |
$0.00 |
| Medical Devices Market in Russia 2009-2013 |
| By Infiniti Research Ltd |
| Medical devices comprise surgical equipment & appliances, diagnostic devices, X-ray, ophthalmic equipment, laboratory devices & diagnostics, dental equipment, medical disposables and others.The Russia ...Read More
|
|
Mar 2010 |
$1500.00 |
|
|
Jan 2013 |
$250.00 |
|
|
Jan 2012 |
$250.00 |
|
|
Jan 2010 |
$149.00 |
|
|
Jan 2010 |
$149.00 |
| 2010 U.S. HMO Medical Centers Industry Report |
| By Barnes Reports |
| The U.S HMO Medical Centers Industry report, published annually by Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics. The report features 2010 current and 20 ...Read More
|
|
Jan 2010 |
$149.00 |
|
|
Oct 2009 |
$149.00 |
|
|
Jan 2010 |
$149.00 |
|
| |
|
|
|
For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9425069161
|
|
|
| |
|
| |
|
|
|
